RMA News & Events

RMA of New York Westchester Adds MVP and Cigna Plans to In-Network  Participation List

RMA of New York Westchester is pleased to introduce MVP and Cigna to its in-network insurance plans. The updated in-network list is as follows:

• Cigna
• MVP
• New York Hotel Trades Council
• New York State Empire Plan for Government Employees (RMA of New York recognized as site of excellence)
• Oxford (OXF) Freedom
• United (UHC) HealthCare
• United Healthcare (UHC) for Mount Sinai Hospital Employees

The extent of coverage, benefits, referral and authorization process vary from policy to policy. It is important that you understand what is covered before you begin treatment, or what the necessary requirements are to get the maximum reimbursement. RMA of New York’s finance department can help you understand your individual benefit.

RMA of New York also works with out-of-network benefits and offers a variety of finance and discount programs. To view these options, please click here.

Moving Forward: Transitions in Fertility Treatment

Transitions are often difficult. When they are unwanted they are more difficult. When they are unwanted and involve our fertility they are particularly difficult. How do we make the decision when to move on to IVF, donor egg, adoption or stopping treatment? How do we balance what is best for us with medical advice? These questions will be explored in a confidential and supportive forum at our Manhattan office.

NEXT GROUP: Sunday, July 12th 10:00AM-12:00AM in RMA of New York's Manhattan Office on the 13th Floor.
To register, please e-mail us or call 212-756-5777.

Westchester Magazine Lists Dr. Jeffrey Klein in its 2007 and 2008 Annual Top Doctors Issue

Westchester Magazine selected Dr. Klein, medical director of RMA of New York Westchester, as one of the best reproductive endocrinologists in the county. Click on the images below to access the list.   

RMA of New York Publishes Study on Reducing Multiples Resulting From IVF

In the competitive IVF industry we live in today, there are IVF centers out there that may, in an attempt to improve apparent success rates, transfer a greater number of embryos. The actual physical, emotional, and financial costs of this strategy may be far greater than realized because of the increased morbidity that is associated with multiple pregnancies. Given that multiple gestation is the greatest risk factor for premature delivery, it is logical to conclude that a cavalier attitude toward multiples will lead to significant future neonatal morbidity, if not mortality.

The current method of calculating IVF success rates considers multiple gestations and prematurely delivered infants to be successes, rather than failures. Patients may see multiple births as an acceptable outcome and may even construe multiple gestations as actualizing a better return on their financial investment. They may be less aware about the greater risk of neonatal morbidity and pregnancy loss. When patients evaluate IVF programs on the basis of Centers for Disease Control and Prevention-reported data, they may conclude that a program with a higher success rate may be preferable to a program with a reduced success rate, even if the latter program has a very low multiple-pregnancy rate.

For the purposes of the study, RMA of New York chose to evaluate how reclassifying IVF success would change the current way we perceive programs. By incorporating higher order multiple gestation rates into the calculation of success rates, we attempted

To access the full article, click here.

An Exclusive Look Inside RMA of New York's IVF Laboratory

RMA of New York recently released an extensive rare view into fertilization, embryo development, and laboratory procedures performed during an IVF cycle. Take an exclusive look inside one of the most advanced, state-of-the-art in vitro fertilization (IVF) laboratories to see how RMA of New York performs IVF and other advanced reproductive technologies using strict identification standards. Medical and laboratory video footage documents egg retrieval, insemination, embryo development from cleavage stage (day 2-3) to blastocyst stage (day 5-6), intracytoplasmic sperm injection (ICSI), assisted hatching, embryo transfer and embryo cryopreservation.

RMA of New York Participates in HOPE Study for Egg Freezing Patients

RMA of New York is participating in EMD Serono'ss Human Oocyte Preservation Experience (HOPE) Registry, an observational study undertaken to evaluate the safety and efficacy of oocyte cryopreservation techniques.  The HOPE Registry aims to track the outcome of oocyte cryopreservation cycles from participating cycles around the country and to validate the efficacy of the different techniques used to freeze and thaw eggs. Results of safety and efficacy of egg freezing techniques along with pregnancy outcomes resultant from the thawing of cryopreserved eggs will be published for public access upon completion of the study.

Stated Dr. Alan Copperman in a press release: "We need to validate the safety and efficacy of egg freezing for it to become a more widely available option for women who for a variety of reasons would like to preserve their fertility. The HOPE Registry is an exciting vehicle that will assist us in the evidence-gathering process and will facilitate the furthering of the science and the acceptance of oocyte cryopreservation as an effective clinical practice."

If you would like to know more about oocyte cryopreservation and the HOPE Study, please contact coordinator Lisa at luberti@rmany.com.

RMA of New York's urologist Dr. Natan-Bar Chama recently joined the Board of Directors of the Society for the Study of Male Reproduction (SSMR).. SSMR is a national professional organization dedicated to encouraging the study, elevating the practice, and improving the quality of care for the subfertile male.

CNN News Article: How to Have a Baby When It's Not So Simple

Dr. Klein Joins Medical Staff of St. Luke's Cornwall Hospital and Introduces Fertility Care to the Mid-Hudson Valley Region

RMA of New York and St. Luke's Cornwall Hospital (SLCH), a clinical affiliate of Mount Sinai Hospital, are pleased to announce that Dr. Klein will be seeing patients for consultations at St. Luke's Cornwall Hospital on 21 Laurel Avenue (suite 9W). Praised SLCH Medical Director Christine Jelalian, MD, "We are proud to welcome Dr. Klein, who brings extensive experience and an impressive record of success in the specialty of infertility to our medical staff. This initiative is another example of SLCH's continued commitment to increase access to physicians in much-needed medical specialties while enhancing facilities, programs and services in our region."

RMA of New York takes pride in being able to offer expanded services to the community of the Mid-Hudson Valley Region. If you are interested in scheduling an appointment or would like to find out more information, please call 914-997-6200 or e-mail info@rmany.com. To visit St. Luke's Cornwall website, click here. To read the press release announcing Dr. Klein's arrival to St. Luke's Cornwall, click here.

New York Magazine Selects RMA Physicians To Be Included In Their Best Doctors Edition for 7th Consecutive Year

We are pleased to announce once again that our physicians are listed as being some of the best fertility specialists in New York State. Click here to access the list.

RMA of New York Physicians Selected in 2008 New York SuperDocs Issue

The four partners of RMA of New York- Drs. Alan Copperman, Lawrence Grunfeld, Tanmoy Mukherjee, and Benjamin Sandler - have been included in 2008 New York SuperDocs issue. This New York SuperDocs list nominates only 5% of the New York physician population as being top in their field.

Marie Claire Magazine Writer Writes About Her Egg Freezing Experience at RMA of New York and appears on Fox's Mike and Juliet Show

April 2008
Marie Claire writer and RMA of New York Patient Sarah Elizabeth Richards talks about her personal experience in freezing her eggs. Click here to read the article. To watch her and Dr. Tanmoy Mukherjee's interview on Fox's Mike and Juliet Show, click here.